SCHEMBL23529287

SCHEMBL23529287

CC(C)(C)C1CN(Cc2cnn(Cc3ccccc3)c(=O)c2)CCN1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.41
▸ ROCK2 O75116 2/20 0.39
▸ ROCK1 Q13464 2/20 0.39
▸ CCR2 P41597 1/20 0.39
▸ AGTR2 P50052 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ MITF O75030 1/20 0.39
▸ S1PR4 O95977 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MCHR1 Q99705 6/20 0.38
▸ CA1 P00915 2/20 0.37
▸ CA2 P00918 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3773661 0.85 AGTR2 (0.50) AGTR2ALDH1A1LMNACA1CA2
SCHEMBL23529285 0.77 HTR1A (0.39) AGTR2CHRM4
SCHEMBL21996912 0.76 S1PR5 (0.40) AGTR2S1PR4S1PR1
SCHEMBL23529288 0.76 TP53 (0.54) ALDH1A1LMNANPC1MITFS1PR4
SCHEMBL5386962 0.76 DRD2 (0.41) ROCK2ROCK1CCR2AGTR2ALDH1A1
SCHEMBL25317215 0.75 LMNA (0.46) AGTR2ALDH1A1LMNAS1PR4S1PR1
SCHEMBL21997577 0.75 CA2 (0.42) AGTR2ALDH1A1S1PR4S1PR1CA1
SCHEMBL2326600 0.74 HRH3 (0.45) ROCK2HTT
SCHEMBL14033566 0.74 AGTR2 (0.46) AGTR2ALDH1A1LMNAMAPTHTT
SCHEMBL23535934 0.74 NPBWR1 (0.44) ALDH1A1HTTMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127273-A1 1 -((6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL)METHYL)PIPERAZINE AND 1 -((6-OXO-1,6-DIHYDROPYRIMIDIN-4-YL)METHYL)PIPERAZINE DERIVATIVES AS PROLYL HYDROXYLASE, HIF-1 ALPHA AND PGK MODULATORS FOR USE IN TREATING INFLAMMATORY DISEASES, CANCER OR INFECTIONS GB004, INC. (US) 2021-06-24 — — WO disclosed
Send feedback